Epigenetic alterations in autoimmune rheumatic diseases

Nature Reviews Rheumatology

Volumn 7, Issue 5, 2011, Pages 263-271

  Ballestar, Esteban ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; B CELL ACTIVATING FACTOR; CPG OLIGODEOXYNUCLEOTIDE; DNA; DNA METHYLTRANSFERASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HISTONE; HISTONE DEACETYLASE INHIBITOR; HYDRALAZINE; INTERLEUKIN 6; MICRORNA;

CPG ISLAND; DISEASE MARKER; DNA METHYLATION; DNA MODIFICATION; DNA POLYMORPHISM; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; EPIGENETICS; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOSS; GENE TARGETING; GENETIC ANALYSIS; GENOME ANALYSIS; HISTONE MODIFICATION; HUMAN; IMMUNOPATHOGENESIS; JUVENILE RHEUMATOID ARTHRITIS; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; X CHROMOSOME INACTIVATION;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; DNA METHYLATION; EPIGENOMICS; GENE EXPRESSION REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RHEUMATIC DISEASES;

EID: 79955623575     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.16     Document Type: Review

References (91)

1. Lie, B. A. & Thorsby, E. Several genes in the extended human MHC contribute to predisposition to autoimmune diseases. Curr. Opin. Immunol. 17, 526-531 (2005). (Pubitemid 41213322)
2. Delgado-Vega, A., Sánchez, E., Löfgren, S., Castillejo-López, C. & Alarcón-Riquelme, M. E. Recent findings on genetics of systemic autoimmune diseases. Curr. Opin. Immunol. 22, 698-705 (2010).
3. Niewold, T. B. et al. Association of the IRF5 risk haplotype with high serum interferon-á activity in systemic lupus erythematosus patients. Arthritis Rheum. 58, 2481-2487 (2008).
4. Kariuki, S. N. et al. Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-á in lupus patients in vivo. J. Immunol. 182, 34-38 (2009).
5. Gourley, M. & Miller, F. W. Mechanisms of disease: Environmental factors in the pathogenesis of rheumatic disease. Nat. Clin. Pract. Rheumatol. 3, 172-180 (2007). (Pubitemid 46416266)
6. Klareskog, L., Padyukov, L., Lorentzen, J. & Alfredsson, L. Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat. Clin. Pract. Rheumatol. 2, 425-433 (2006). (Pubitemid 44203826)
7. Esteller, M. Epigenetics in cancer. N. Engl. J. Med. 358, 1148-1159 (2008).
8. Allis, C. D., Jenuwein, T. & Reinberg, D. in Epigenetics Ch. 3: Overview and Concepts (eds Allis, C. D., Jenuwein, T. & Reinberg, D.) 23-62 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2007).
9. Huertas, D., Sendra, R. & Muñoz, P. Chromatin dynamics coupled to DNA repair. Epigenetics 4, 31-42 (2009).
10. Corpet, A. & Almouzni, G. Making copies of chromatin: the challenge of nucleosomal organization and epigenetic information. Trends Cell Biol. 19, 29-41 (2009).
11. Bird, A. Perceptions of epigenetics. Nature 447, 396-398 (2007). (Pubitemid 46816744)
12. Sandelin, A. et al. Mammalian RNA polymerase II core promoters: insights from genome-wide studies. Nat. Rev. Genet. 8, 424-436 (2007). (Pubitemid 46789243)
13. Irizarry, R. A. et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 178-186 (2009).
14. Goll, M. G. & Bestor, T. H. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 74, 481-514 (2005). (Pubitemid 40995515)
15. Garcia-Manero, G. Demethylating agents in myeloid malignancies. Curr. Opin. Oncol. 20, 705-710 (2008).
16. Bhutani, N. et al. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463, 1042-1047 (2010).
17. Bruniquel, D. & Schwartz, R. H. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat. Immunol. 4, 235-240 (2003). (Pubitemid 36322132)
18. Ooi, S. K. & Bestor, T. H. The colorful history of active DNA demethylation. Cell 133, 1145-1148 (2008). (Pubitemid 351852922)
19. Fritz, E. L. & Papavasiliou, F. N. Cytidine deaminases: AIDing DNA demethylation? Genes Dev. 24, 2107-2114 (2010).
20. Rai, K. et al. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 135, 1201-1212 (2008).
21. Salvador, J. M. et al. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16, 499-508 (2002). (Pubitemid 34442575)
22. Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
23. Ito, S. et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466, 1129-1133 (2010).
24. Kouzarides, T. Chromatin modifications and their function. Cell 128, 693-705 (2007). (Pubitemid 46273577)
25. Allis, C. D. et al. New nomenclature for chromatin-modifying enzymes. Cell 131, 633-636 (2007). (Pubitemid 350089969)
26. Biancotto, C., Frigè, G. & Minucci, S. Histone modification therapy of cancer. Adv. Genet. 70, 341-386 (2010).
27. Kraus, W. L. & Wong, J. Nuclear receptor-dependent transcription with chromatin. Is it all about enzymes? Eur. J. Biochem. 269, 2275-2283 (2002). (Pubitemid 34526517)
28. Schwartz, Y. B. et al. Alternative epigenetic chromatin states of polycomb target genes. PLoS Genet. 6, e1000805 (2010).
29. Bell, C. G. & Beck, S. The epigenomic interface between genome and environment in common complex diseases. Brief. Funct. Genomics 9, 477-485 (2010).
30. Richly, H., Lange. M., Simboeck. E. & Di Croce, L. Setting and resetting of epigenetic marks in malignant transformation and development. Bioessays 32, 669-679 (2010).
31. Esteller, M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8, 286-298 (2007). (Pubitemid 46439286)
32. Ehrlich, M. DNA hypomethylation in cancer cells. Epigenomics 1, 239-259 (2009).
33. Konkel, M. K. & Batzer, M. A. A mobile threat to genome stability: The impact of non-LTR retrotransposons upon the human genome. Semin. Cancer Biol. 20, 211-221 (2010).
34. Schlesinger, Y. et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet. 39, 232-236 (2007). (Pubitemid 46184355)
35. Widschwendter, M. et al. Epigenetic stem cell signature in cancer. Nat. Genet. 39, 157-158 (2007). (Pubitemid 46184343)
36. Di Croce, L. Chromatin modifying activity of leukaemia associated fusion proteins. Hum. Mol. Genet. 14 (Suppl. 1), R77-R84 (2005). (Pubitemid 40542623)
37. Ballestar, E. et al. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J. 22, 6335-6345 (2003). (Pubitemid 37522590)
38. Cooper, G. S., Miller, F. W. & Pandey, J. P. The role of genetic factors in autoimmune disease: implications for environmental research. Environ. Health Perspect. 107 (Suppl. 5), 693-700 (1999). (Pubitemid 29527772)
39. Salvetti, M., Ristori, G., Bomprezzi, R., Pozzilli, P. & Leslie, R. D. Twins: mirrors of the immune system. Immunol. Today 21, 342-347 (2000). (Pubitemid 30428306)
40. Fraga, M. F. et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl Acad. Sci. USA 102, 10604-10609 (2005). (Pubitemid 41061601)
41. Kaminsky, Z. A. et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat. Genet. 41, 240-245 (2009).
42. Cezar, G. G. et al. Genome-wide epigenetic alterations in cloned bovine fetuses. Biol. Reprod. 68, 1009-1014 (2003). (Pubitemid 36245849)
43. Young, L. E. et al. Conservation of IGF2-H19 and IGF2R imprinting in sheep: effects of somatic cell nuclear transfer. Mech. Dev. 120, 1433-1442 (2003). (Pubitemid 37488032)
44. Heijmans, B. T. et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl Acad. Sci. USA 105, 17046-17049 (2008).
45. Sinclair, K. D. et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc. Natl Acad. Sci. USA 104, 19351-19356 (2007).
46. Cannat, A. & Seligmann, M. Induction by isoniazid and hydrallazine of antinuclear factors in mice. Clin. Exp. Immunol. 3, 99-105 (1968).
47. Richardson, B. Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells. Hum. Immunol. 17, 456-470 (1986). (Pubitemid 17198980)
48. Cornacchia, E. et al. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J. Immunol. 140, 2197-2200 (1988). (Pubitemid 18098475)
49. Quddus, J. et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Invest. 92, 38-53 (1993). (Pubitemid 23208979)
50. Yung, R. L., Quddus, J., Chrisp, C. E., Johnson, K. J. & Richardson, B. C. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J. Immunol. 154, 3025-3035 (1995).
51. Blomgren, S. E., Condemi, J. J. & Vaughan, J. H. Procainamide-induced lupus erythematosus. Clinical and laboratory observations. Am. J. Med. 52, 338-348 (1972).
52. Richardson, B. C. et al. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum. 35, 647-662 (1992).
53. Richardson, B. et al. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 33, 1665-1673 (1990).
54. Corvetta, A., Della Bitta, R., Luchetti, M. M. & Pomponio, G. 5-Methylcytosine content of DNA in blood, synovial mononuclear cells and synovial tissue from patients affected by autoimmune rheumatic diseases. J. Chromatogr. 566, 481-491 (1991).
55. Huck, S. & Zouali, M. DNA methylation: a potential pathway to abnormal autoreactive lupus B cells. Clin. Immunol. Immunopathol. 80, 1-8 (1996). (Pubitemid 26227826)
56. Javierre, B. M. et al. Changes in the pattern of DNA methylation associated with twin discordance in systemic lupus erythematosus. Genome Res. 20, 170-179 (2010).
57. Fraga, M. F. & Esteller, M. Epigenetics and aging: the targets and the marks. Trends Genet. 23, 413-418 (2007). (Pubitemid 47088010)
58. Maegawa, S. et al. Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res. 20, 332-340 (2010).
59. Wilson, V. L. & Jones, P. A. DNA methylation decreases in aging but not in immortal cells. Science 220, 1055-1057 (1983). (Pubitemid 13090144)
60. Zhang, W. et al. Comparison of global DNA methylation profiles in replicative versus premature senescence. Life Sci. 83, 475-480 (2008).
61. Deng, C. et al. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum. 44, 397-407 (2001).
62. Sawalha, A. H. et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun. 9, 368-378 (2008). (Pubitemid 351791493)
63. Tili, E., Michaille, J. J., Costinean, S., Croce, C. M. MicroRNAs, the immune system and rheumatic disease. Nat. Clin. Pract. Rheumatol. 4, 534-541 (2008).
64. Pan, W. et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 184, 6773-6781 (2010).
65. Li, Y. et al. Overexpression of the growth arrest and DNA damage-induced 45á gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheum. 62, 1438-1447 (2010).
66. Hsu, H.-C. et al. Inhibition of the catalytic function of activation-induced cytidine deaminase (AICDA) promotes apoptosis of germinal center B cells. Arthritis Rheum. doi:10.1002/art.30257.
67. Lu, Q. et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum. 46, 1282-1291 (2002). (Pubitemid 34525836)
68. Oelke, K. et al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum. 50, 1850-1860 (2004). (Pubitemid 38725098)
69. Lu, Q. et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 179, 6352-6358 (2007).
70. Kaplan, M. J., Lu, Q., Wu, A., Attwood, J. & Richardson, B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J. Immunol. 172, 3652-3661 (2004). (Pubitemid 38337948)
71. Garaud, S. et al. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J. Immunol. 182, 5623-5632 (2009).
72. Nile, C. J., Read, R. C., Akil, M., Duff, G. W. & Wilson, A. G. Methylation status of a single CpG site in the IL-6 promoter is related to IL-6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum. 58, 2686-2693 (2008).
73. Neidhart, M. et al. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum. 43, 2634-2647 (2000). (Pubitemid 32001729)
74. Karouzakis, E., Gay, R. E., Michel, B. A., Gay, S. & Neidhart, M. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 60, 3613-3622 (2009).
75. Stanczyk, J. et al. Altered expression of miR-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum. 63, 373-381 (2011).
76. Lane, A. A. & Chabner, B. A. Histone deacetylase inhibitors in cancer therapy. J. Clin. Oncol. 27, 5459-5468 (2009).
77. Mishra, N. et al. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J. Clin. Invest. 111, 539-552 (2003). (Pubitemid 36228011)
78. Reilly, C. M. et al. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. J. Immunol. 173, 4171-4178 (2004). (Pubitemid 39280783)
79. Vojinovic, J. et al. Safety and efficacy of an oral histone deacetylase inhibitor in systemic onset juvenile idiopathic arthritis. Arthritis Rheum. doi:10.1002/art.30238.
80. Dörner, T., Radbruch, A. & Burmester, G. R. B-cell-directed therapies for autoimmune disease. Nat. Rev. Rheumatol. 5, 433-441 (2009).
81. Petri, M. et al., Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum. 58, 2453-2459 (2008).
82. Sanz, I. & Lee, F. E. B cells as therapeutic targets in SLE. Nat. Rev. Rheumatol. 6, 326-337 (2010).
83. Mazari, L., Ouarzane, M. & Zouali, M. Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc. Natl Acad. Sci. USA 104, 6317-6322 (2007). (Pubitemid 47186092)
84. Baranzini, S. E. et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 464, 1351-1356 (2010).
85. Mastronardi, F. G., Noor, A., Wood, D. D., Paton, T. & Moscarello, M. A. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J. Neurosci. Res. 85, 2006-2016 (2007). (Pubitemid 47051489)
86. Basu, D. et al. Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. J. Immunol. 183, 3481-3487 (2009).
87. Mikkelsen, T. S. et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553-560 (2007). (Pubitemid 47206934)
88. Ballestar, E. & Wolffe, A. P. Methyl-CpG-binding proteins. Targeting specific gene repression. Eur. J. Biochem. 268, 1-6 (2001). (Pubitemid 32052241)
89. Dhasarathy, A. & Wade, P. A. The MBD protein family-reading an epigenetic mark? Mutat. Res. 647, 39-43 (2008).
90. Ooi, S. K. et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448, 714-717 (2007). (Pubitemid 47236857)
91. de la Cruz, X., Lois, S., Sánchez-Molina, S. & Martínez-Balbás, M. A. Do protein motifs read the histone code? Bioessays 27, 164-175 (2005). (Pubitemid 40292388)